Bullous adult T-cell lymphoma/leukemia and human T-cell lymphotropic virus-1 associated myelopathy in a 60-year-old man.
Here we report a case of vesiculobullous adult T-cell lymphoma/leukemia (ATLL); to our knowledge the first such report of this presentation. We emphasize the difficulty in clinically distinguishing ATLL from cutaneous t-cell lymphoma. The case is further distinguished by the simultaneous presentation of human T-cell lymphotropic virus-1-related myelopathy in this patient, an unusual occurrence.
Michael
Elias J
EJ
Department of Dermatology, St Luke's/Roosevelt Hospital, New York City, NY 10025, USA.
Shaffer
Joseph J
JJ
Collins
Henry E
HE
Grossman
Marc E
ME
D000971:Antineoplastic Combined Chemotherapy Protocols; D001707:Biopsy, Needle; D003520:Cyclophosphamide; D004317:Doxorubicin; D017809:Fatal Outcome; D005500:Follow-Up Studies; D015368:Human T-lymphotropic virus 1 / Q000302:isolation & purification*; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011241:Prednisone; D012720:Severity of Illness Index; D013118:Spinal Cord Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D014750:Vincristine
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone